FdaApplication
NDA 020358
Identifiers
- fda_app_no: NDA020358
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1996-10-04 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE;ORAL |
| WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 200MG | TABLET, EXTENDED RELEASE;ORAL |
| WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
| WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 50MG | TABLET, EXTENDED RELEASE;ORAL |
4 products